PHARMACOECONOMIC EVALUATION OF RUFINAMIDE USE FOR THE LENNOX-GASTAUT SYNDROME TREATMENT

• 主要な著者: N. K. Mazina (著者), P. V. Mazin (著者), Yu. V. Kislitsin (著者), E. M. Markova (著者)
• フォーマット: 図書
• 出版事項: IRBIS LLC, 2016-04-01T00:00:00Z.
• 主題: article
• オンライン･アクセス: Connect to this object online.

Among epileptic encephalopathies, the Lennox-Gastaut syndrome is considered to be one of the most severe. It is a childhood-onset disease that leads to early disability and mental retardation and is associated with significant costs of medical care and patient nursing. In the Russian Federation, the...